Finance

ProMIS Neurosciences concludes ATM equity offering and gains FDA Fast Track designation for PMN310, advancing Alzheimer's treatment prospects. #ProMISNeurosciences #PMN310

AstraZeneca commits $50B to US manufacturing and R&D, boosting innovation and production capacity. #AstraZeneca #PharmaInvestment

Flux Power Holdings revises debt agreements, extending loan maturities to enhance liquidity and support growth. #FluxPowerHoldings #DebtAmendment

Datavault AI secures $50M at-the-market equity deal with Maxim Group to fuel growth and innovation. #DatavaultAI #EquityAgreement

Radiopharm Theranostics strengthens expertise by appointing Dr. Oliver Sartor to its Scientific Advisory Board. #RadiopharmTheranostics #ScientificAdvisory

Coterra Energy announces Q2 realized prices with $35M in derivative settlements, reflecting strong commodity management. #CoterraEnergy #Q22025Results

Mobile Infrastructure Corp announces August payment of preferred stock dividends, reflecting financial stability and shareholder value commitment. #MobileInfrastructure #Dividends

Webster Financial announces transition in Chief Accounting Officer role, reinforcing leadership in financial reporting. #WebsterFinancial #LeadershipTransition

XTL Biopharmaceuticals delays shareholder meeting after failing to meet quorum, raising governance and investor engagement concerns. #XTLBiopharma #ShareholderMeeting

HeartFlow targets IPO driven by rising revenue despite significant operating losses, highlighting growth potential and financial challenges. #HeartFlow #IPO